GORE® CARDIOFORM Septal Occluder and Antiplatelet medical management for reduction of recurrent stroke in patients with Patent Foremen Ovale (PFO): The REDUCE post approval study,
Role: Investigator,
W.L. Gore & Associates, Inc.,
(06/2024 - 06/2025)
Status: Approved
Internal
Risk of Hemorrhagic Transformation in Patients who Required Aggressive Blood Pressure Reduction Prior to IV-Thrombolytic Treatment,
Role: PI,
LLU Dept. of Neurology,
(06/2024)
Status: Approved
The incidence of seizures on electroencephalography (EEG) in non-neurologic intensive care unit (ICU) settings,
Role: PI,
LLU Dept. of Neurology,
(12/2023)
Status: Approved
Yield of MRI brain in acute nontraumatic intraparenchymal hemorrhage: A Retrospective Study,
Role: PI,
LLU Dept. of Neurology,
(09/2023)
Status: Approved
Stroke, Thrombectomy, and Aneurysm Registry (STAR),
Role: Investigator,
LLU Dept. of Neurosurgery,
(07/2021)
Status: Approved
Identification regional differences in acute stroke admissions during the COVID-19 pandemic,
Role: PI,
LLU Dept. of Neurology,
(08/2020)
Status: Approved
Identify factors that delay IV TPA treatment for acute ischemic stroke in emergency department,
Role: PI,
LLU Dept. of Neurology,
(10/2018 - 10/2019)
Status: Completed
Effect of hydrogen gas on acute large vessel ischemic stroke: a pilot study,
Role: Co-Investigator,
LLU School of Medicine,
(05/2017 - 09/2022)
Status: Closed
Non-Profit Organization
Platelet-Oriented Inhibition in New Tia and Minor Ischemic Stroke (POINT) Trial,
Role: Principal Investigator,
EMMES Corporation,
(06/2014 - 08/2014)
Status: Closed